Anthracycline cardiotoxicity: looking for new therapeutic approaches targeting cell senescence?
Cardiovasc Res
.
2018 Aug 1;114(10):1304-1305.
doi: 10.1093/cvr/cvy108.
Authors
Shariq Abid
1
2
,
Larissa Lipskaia
1
2
,
Serge Adnot
1
2
Affiliations
1
INSERM U955 and Département de Physiologie, Hôpital Henri Mondor, AP-HP, DHU A-TVB, 94010 Créteil, France.
2
Université Paris-Est Créteil (UPEC), Creteil, France.
PMID:
29718137
DOI:
10.1093/cvr/cvy108
No abstract available
Publication types
Editorial
Comment
MeSH terms
Animals
Anthracyclines*
Antibiotics, Antineoplastic
Cellular Senescence
Doxorubicin
Mice
Resveratrol*
Substances
Anthracyclines
Antibiotics, Antineoplastic
Doxorubicin
Resveratrol